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Growing innovations for the  
bioeconomy
Agriculture is often viewed as a source of problems needing innovative solutions. But agriculture 
can actually be a source of innovations for the bioeconomy, if researchers embrace the cultural 
changes needed.
Angela Karp, Michael H. Beale, Frédéric Beaudoin, Peter J. Eastmond, Andrew L. Neal, Ian F. Shield,  
Belinda J. Townsend and Achim Dobermann
Many nations have now published strategies outlining their plans for the bioeconomy1–3 — the section 
of the economy fuelled by scientific and 
technological innovations in the biosciences. 
The bioeconomy promises to be a renewed 
source of economic growth and job creation, 
with over 22 million people already 
employed in the sector (worth more than 
€2 trillion annually) in the European Union, 
and over 4 million in the US.
Alongside its economic promise, the 
bioeconomy is anticipated to contribute 
significantly to the implementation of 
the UN Sustainable Development Goals 
(www.un.org/sustainabledevelopment/
sustainable-development-goals) through its 
impact on health, food security, sustainable 
energy and the conservation of scarce 
natural resources. It is the integration 
of science with business and society, 
and the triple promise of increasing 
innovation, growing economies and solving 
sustainable development challenges, that 
give the bioeconomy so much power as a 
policy concept.
The bioeconomy aspirations of 
governments and industries have arisen 
from the recognition of the enormous 
potential of recent technological advances 
in the biosciences — particularly high-
throughput genome sequencing and ‘omic’ 
technologies (such as transcriptomics, 
proteomics and metabolomics), 
high-throughput phenotyping (Fig. 1), 
computational biology and synthetic 
biology4. These technologies enable 
the generation of huge datasets and the 
integration of knowledge across all levels 
of biological organization, from genes 
to individuals to communities. They 
have profoundly altered the way causal 
gene discovery, functional analysis, 
whole-organism design, crop and animal 
improvement and whole-systems analysis 
can be approached and achieved. As 
such, these technologies are anticipated 
to drive truly transformational changes in 
human health, agriculture and resource 
management, and in the manufacture 
of cleaner and greener energy and 
industrial products from renewable and 
more sustainable sources. The ability 
to sequence and compare genomes of 
patients cheaply and quickly, for example, 
is anticipated to lead to more personalized 
healthcare. Biotechnology and genome 
editing are anticipated to significantly 
accelerate the breeding of more resilient 
crops and the development of smart crop 
protection systems.
The agri-economy
Agriculture remains the essential 
cornerstone of food provision for the 
world’s growing population. Unfortunately, 
however, agriculture is often considered 
to be a source of problems that require 
innovative solutions, rather than being seen 
as a source of innovations. Publically funded 
agricultural research is often viewed as solid 
and traditional, rather than progressive and 
game-changing. The decline in the number 
of researchers in agricultural disciplines such 
as agronomy, weed science, crop physiology 
and breeding, and the loss of publically 
funded breeding programmes in many 
countries, are symptomatic of these views. 
At the same time, most private investments 
in the bioeconomy have not been directed 
at agriculture, but at the pharmaceutical 
and biomedicine industries, followed by the 
green chemistry, biomaterials and industrial 
biotechnology industries.
Agriculture is undergoing a 
transformation due to the use of Global 
Positioning Systems in concert with 
remote sensors and intelligent systems. For 
instance, on-board tractor performance 
monitoring systems now enable farmers to 
optimize input operations to enhance field 
productivity5. These innovations, however, 
are not being driven by researchers in the 
agricultural sciences, but rather by experts 
in information management technologies, 
electronics and engineering.
In Europe, a major path to the 
bioeconomy has been the establishment 
of ‘bioeconomy clusters’ — regional 
aggregations of small- and medium-
sized enterprises, research centres, 
universities and (occasionally) investors 
working towards shared goals. This 
development was spurred by Germany’s 
first bioeconomy cluster in Halle, 
Saxony-Anhalt (http://en.bioeconomy.de). 
Here, timber, chemical, plastic material and 
plant engineering industries and research 
organizations work together on the use 
of non-food biomass for energy and new 
materials production. Facilities such as 
biorefineries are often at the centre of such 
clusters, such as the Fraunhofer Centre for 
Chemical-Biotechnological Processes in 
Leuna, which uses cutting-edge chemical 
and biotechnological technologies for 
the extraction of chemical products 
from biomass for diverse industrial uses. 
Similar aggregations have been established 
throughout the world, and include 
biomedical centres that bring together all 
manner of businesses, from pharmaceutical 
companies to device manufacturers.
No equivalent bioeconomy clusters have 
so far been developed specifically in the 
agricultural sector, although some, such as 
the UK BioVale cluster (www.biovale.org) 
of Yorkshire and the Humber (also 
concentrated around a biorefinery), carry 
out some research into the utilization of 
food waste. Government initiatives aimed 
at connecting and coordinating agricultural 
research activities with industries (such 
as AgriTech centres in the UK) are also a 
step in the right direction. For instance, the 
© 2015 Macmillan Publishers Limited. All rights reserved
2 NATURE PLANTS | VOL 1 | DECEMBER 2015 | www.nature.com/natureplants
comment
newly established UK AgriMetrics centre 
(www.agrimetrics.co.uk) serves as a portal 
to all publically available data relevant 
to the food system. This agricultural 
informatics platform combines all the 
necessary software tools for the integration 
of large datasets from crop and animal 
breeding, agronomy and farming systems, 
according to the needs of users throughout 
the food sector.
Complexity, conflict and constraint
Sustainable agriculture and the provision 
of sufficient, healthy and safe food rank 
highly among the objectives of most national 
bioeconomy strategies. Despite this, the 
agricultural sector has been slower in 
realising opportunities in the bioeconomy. 
There are arguably four main reasons 
why the agricultural sciences are lagging 
behind: (1) the complexities inherent in 
the management of agricultural production 
and agricultural food chains; (2) conflicts 
over land and resource use; (3) government 
restrictions on some technologies; and 
(4) the challenges facing agricultural 
research organizations in achieving a 
balance between research and innovation.
Complex conditions. Agriculture 
is inherently complex and, to 
borrow words from Thomas Hardy’s 
Tess of the d’Urbervilles, affected by the 
“persistence of the unforeseen”. It is 
fundamentally different from industries 
such as manufacturing, in having to manage 
large environmental variability, even within 
a single location, as well as unpredictable 
challenges, such as extreme weather 
events and new pests or diseases. It also 
requires linkages between many different 
types of stakeholders, from farmers, who 
make independent choices about what 
they produce and how they do it, to 
consumers, who express their views about 
food production through their purchase 
choices. Furthermore, new agriculturally 
based products (such as pharmaceuticals 
or chemicals from crop biomass) will often 
have to compete with existing products 
with proven safety track records, or cope 
with new and volatile markets. The complex 
issues faced by many large oil and electricity 
companies when trying to secure sufficient 
crop feedstock supply for bioenergy and 
biofuels, within a market characterized 
by rapidly changing oil prices, fluctuating 
public acceptance and unstable policy 
interventions, are a case in point6.
Conflicting demands. Concerns over 
potential conflicts arising from the use 
of land for bioenergy versus food crops, 
or the use of feedstocks (such as grain) 
for biofuels and bioenergy rather than 
for human consumption, have led to 
diametrically opposed visions in national 
bioeconomy strategies3. Some government 
strategies, such as those of Germany and 
the US, positively encourage the use of 
agricultural, forest and biomass crops for 
fuel and chemical production at a large 
scale — although they fall short of directly 
addressing issues surrounding sustainable 
supply7. Others, such as the EU and UK 
strategies, emphasize the use of food waste 
and agricultural or forest residues for 
these purposes. These contrasting visions 
reflect differences in the strength of major 
sectors (such as the forestry, agriculture 
and industrial biotechnology sectors) as 
well as differences in the priority given 
to environmental concerns, and current 
land-use and availability. The labyrinth of 
ever-changing policies and government 
interventions aimed at resolving such issues 
is not conducive for long-term investments 
in the agro-bioeconomy8.
Regulatory hurdles. Many agricultural 
scientists, faced with issues over public 
acceptance of new technologies and 
government restrictions on using genetically 
manipulated (GM) crops, feel unable to 
capitalize on many technical advances. The 
increase in land area under GM crops over 
the past ten years constitutes the biggest 
adoption of an agricultural innovation so far, 
but regulations have severely restricted their 
use in many places, including Europe, and 
the costs involved make GM an improbable 
route for all but the largest companies. 
Newer technologies, such as genome editing, 
have yet to run the full gauntlet of critical 
examination before their deployment 
potential is known9. Such issues are not 
confined to agriculture, but investments in 
human health are larger and the benefits 
more directly realized, so the risks are 
more acceptable.
Entrepreneurial impediments. Many 
farmers are great entrepreneurs. Scientists 
within agricultural research institutes 
and universities, on the other hand, are 
often constrained by the ever-changing 
and sometimes conflicting expectations 
of governments, funding agencies and 
sponsors, as well as the public, when it 
comes to entrepreneurism10. Most walk a 
precarious tightrope to achieve a balanced 
research portfolio (in the eyes of their 
appraisers and funders) that includes the 
delivery of scientific excellence, strategic 
relevance, impact and commercial output, 
while also avoiding being labelled as ‘no 
longer independent’ by the tax-paying 
public, who ultimately fund them11.
Figure 1 | A Field Scanalyzer, recently installed at Rothamsted Research in the UK. The device 
supports a motorized measuring platform with multiple sensors. It is fully automated and can operate 
continuously. On-board illumination facilitates the data collection. Sensors include multi-wavelength 
imaging systems, a sensor to measure chlorophyll fluorescence decay kinetics, and a laser system for 
3D visualization and crop height determination. Technologies such as this provide field phenotype data 
of unprecedented detail and accuracy that can inform new crop improvement strategies, and thereby 
help fuel the bioeconomy.
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Cultivating cultural change
Agricultural organizations have an 
important part to play in contributing 
scientific evidence to debates in order 
to help overcome many of the above-
mentioned hurdles in the development of an 
agricultural bioeconomy. Importantly, they 
can also change significantly their approach 
to innovation and entrepreneurism. Most 
of the published national bioeconomy 
strategies2,3 recognize the need for change 
in this respect, and suggest mechanisms 
and instruments that agricultural research 
organizations can build on.
The need for interdisciplinary research 
and integration across the life sciences, with 
more information sharing and cooperation 
between the public and private sectors, 
and more international cooperation and 
knowledge pooling, is emphasized in most 
government strategies. The agricultural 
sector has a head start in this, as past trends 
have positively encouraged cooperation 
and knowledge pooling, and new initiatives 
(such as AgriTech, mentioned above), are 
already building on this approach. Also 
recognized in most strategies is the need 
for new measures that will accelerate 
technology transfer through problem 
solving and the identification of market 
needs. The way that the Fraunhofer 
Institutes in Germany work by teaming 
industry with research organizations to 
scale up cutting-edge research into working 
technologies on an industrial timetable 
is seen as a useful model by countries 
worldwide, and could be applied in the 
agricultural sector.
Most bioeconomy strategies also 
acknowledge the need to streamline current 
legislation and regulatory bottlenecks, as 
well as to increase dialogue with the public 
and to establish appropriate ethics and 
security platforms. The EU, for example, 
has created a Bioeconomy Panel to foster 
an open dialogue and enhance coherence 
among policies, initiatives and the economic 
sector, and a Bioeconomy Observatory to 
assess progress and impact. Some strategies 
also anticipate legal and regulatory reform. 
All these developments could help overcome 
some of the difficulties faced with the 
adoption of new technologies in crop 
breeding. The need for new approaches to 
the funding of research and the training of 
researchers to encourage innovation and 
entrepreneurship is also identified. The 
integration of translational research into 
academic coursework and offering training 
in entrepreneurism to faculty members are 
some of the solutions proposed.
Agricultural science has many attributes 
that suggest it should be able to embrace 
these changes and become a major 
contributor to the bioeconomy. It is an 
interdisciplinary field by nature and has 
a long history of technology transfer and 
stakeholder engagement. Transformation 
in farming is continual, and agricultural 
researchers have long grappled with the 
biology of hugely complex managed 
agricultural systems in order to make 
interventions. Many of the solutions 
developed may have applications outside 
of agriculture itself: smart sensing systems 
that report on crop health status could 
have applications for monitoring health 
of trees and other keystone species in 
natural ecosystems; methods based on 
bioremediation for managing contaminants 
and pollutants arising from agricultural 
land use could have applications in cities; 
plant chemistry, evolved to combat pest 
attacks, can be a source of novel drugs for 
humans; and agricultural soils could be a 
source of novel microbes or enzymes for 
industrial processes, or of antibiotics to help 
tackle human health problems such as anti-
microbial resistance.
An agriculturally based bioeconomy, 
however, cannot be achieved by simply 
revitalizing or re-labelling individual areas 
of agricultural science, such as soil or crop 
science. Economic impact is an unremitting 
metric of the bioeconomy, and many 
agricultural research organizations will need 
to engender a more ideas-led and innovative 
culture to compete7. Interdisciplinary 
approaches involving physicists, chemists, 
engineers and computational biologists, 
as well as entrepreneurial thinking, will 
be crucial for success. To stimulate the 
generation of ideas outside the traditional 
agricultural box, and to introduce 
economic opportunities to farming and 
agriculture, new partners should be sought 
from a wide range of sectors, including 
device manufacturers and information 
technologists, and from across existing 
farm-to-product value chains.
The time for change is now. It is 
imperative that agricultural research 
organizations embrace the cultural 
changes suggested in the action plans of 
many bioeconomy strategy documents, 
and thereby the opportunities offered 
by the bioeconomy. There could 
not be a more exciting time to be in 
agricultural science. ❐
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